Impact of Immunohistochemistry Subtypes on Survival Outcomes in Breast Cancer with Spinal Metastases: A Comprehensive Review and Meta-Analysis - Scorecard - MDSpire

Impact of Immunohistochemistry Subtypes on Survival Outcomes in Breast Cancer with Spinal Metastases: A Comprehensive Review and Meta-Analysis

  • By

  • Fon-Yih Tsuang

  • Yun-Heng Li

  • Ting-Li Shen

  • Chiun-Sheng Huang

  • Chung Liang Chai

  • February 21, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Immunohistochemistry Subtypes on Survival Outcomes in Breast Cancer with Spinal Metastases: A Comprehensive Review and Meta-Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsInclude the prognostic role of immunohistochemistry.
Target Population
Care Setting

Key Highlights

  • source_clarity

Guideline-Based Recommendations

Diagnosis

    Management

    • S
    • p
    • e
    • c
    • i
    • f
    • y
    • t
    • y
    • p
    • e
    • s
    • o
    • f
    • p
    • a
    • l
    • l
    • i
    • a
    • t
    • i
    • v
    • e
    • i
    • n
    • t
    • e
    • r
    • v
    • e
    • n
    • t
    • i
    • o
    • n
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Detail treatment options based on immunohistochemistry subtypes.

        Clinical Best Practices

        • examples

        References

        Original Source(s)

        Impact of Immunohistochemistry Subtypes on Survival Outcomes in Breast Cancer with Spinal Metastases: A Comprehensive Review and Meta-Analysis

        • by Fon-Yih Tsuang, Yun-Heng Li, Ting-Li Shen, Chiun-Sheng Huang, Chung Liang Chai

        • February 21, 2026

        Related Content

        Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

        Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

        Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications